Figure 6 , A – D are expressed as the means ± SDs. The data were analyzed with one-way ANOVA for multiple comparisons in SPSS 16.0 software and plotted with GraphPad Prism 6.0. E and F , MAP4K4 overexpression and/or SASH1 silencing promoted the expression of YAP1 target genes, as shown by qRT‒PCR and immunoblotting. The Ct values of CTGF and CYR61 are expressed as the means ± SDs and were analyzed with one-way ANOVA for multiple comparisons. G and H , Significant increases in the expression of ERα , ERβ and PGR resulted from ectopic MAP4K4 expression and/or SASH1 silencing in MCF-7 cells, as indicated by qRT‒PCR. Ectopic MAP4K4 expression and/or SASH1 silencing resulted in increased expression of TP53 . The Ct values of ERα , ERβ , PGR and TP53 are expressed as the means ± SDs and were analyzed with one-way ANOVA for multiple comparisons. I , ectopic MAP4K4 and/or SASH1 silencing increased ERα expression in MCF-7 cells, as indicated by immunoblotting. J , the reduction in the p-YAP1 level in the MAP4K4-LATS-SASH1-YAP1 axis induced by PF-06260933 treatment was abolished by LATS2 silencing but not by LATS1 silencing. MCF-7 cells were transfected with either of two LATS1 siRNAs or LATS2 siRNAs. Twenty-four hours after transfection, the cells were treated with 20 μM PF-06260933 for 12 h, lysed and subjected to western blotting. K , downregulation of MAP4K4 and YAP1 and decreased levels of p-LATS2 resulted from PF-06260933 treatment of MCF-7 cells. MCF-7 cells were treated with 20 μM PF-06260933 for 12 h and lysed. The phosphorylation of endogenous MAP4K4 and SASH1 was assessed by the Phos-tag assay. # p < 0.05, ∗ p < 0.01, ∗∗ p < 0.001 versus control. L , downregulation of ERα, CYR61, CTGF, and YAP1 and an increased level of SASH1 resulted from PF-06260933 treatment of MCF-7 cells. The protein densitometry data in
, I – K are expressed as the means ± SDs and were analyzed with one-way ANOVA for multiple comparisons. M , schematic diagram showing that YAP1 dephosphorylation and nuclear translocation of YAP1/TAZ are triggered by the combined effects of MAP4K4 upregulation and SASH1 silencing to activate the MAP4K4-LATS2-SASH1-YAP1/TAZ-TEAD4 cascade. N , schematic diagram showing that YAP1 downregulation and a decrease in the nuclear translocation of YAP1/TAZ resulted from MAP4K4 blockade caused by the use of MAP4K4-specific inhibitors or shRNAs to inhibit the activation of the MAP4K4-LATS2-SASH1-YAP1/TAZ-TEAD4 cascade. The schematic diagram was generated by Figdraw ( www.figdraw.com ). " width="100%" height="100%">
Journal: The Journal of Biological Chemistry
Article Title: Blockade of a novel MAP4K4-LATS2-SASH1-YAP1 cascade inhibits tumorigenesis and metastasis in luminal breast cancer
doi: 10.1016/j.jbc.2024.107309
Figure Lengend Snippet: Increased nuclear translocation of YAP1/TAZ and upregulation of ER and PGR were observed in response to MAP4K4 upregulation and SASH1 silencing. A , MAP4K4 overexpression and/or SASH1 silencing promoted YAP/TAZ nuclear translocation in MCF-7 cells. MCF-7 cells were transfected with different combinations of Flag- MAP4K4 and SASH1 -specific shRNAs. Forty-eight hours after transfection, the cells were lysed, and the nuclear and cytoplasmic proteins were separately extracted with nuclear and cytoplasmic protein extraction kits according to the manufacturer’s protocol. GAPDH and Lamin A/C were used as the internal controls for cytoplasmic and nuclear proteins, respectively, to assess cross-contamination between the cytosolic and nuclear fractions and quantify the expression of YAP1 and TAZ in the cytoplasm and nucleus. The blots shown are representative of three independent experiments. N: nucleus, C: cytoplasm. B , MAP4K4 overexpression and SASH1 silencing promoted the interaction of YAP1 with TEAD4 in MCF-7 cells. Flag- MAP4K4 , SASH1- specific shRNA, and GFP- TEAD4 were introduced into MCF-7 cells in different combinations. Forty-eight hours after transfection, the cells were lysed and subjected to IP-WB. Endo-YAP1 was immunoprecipitated with an anti-YAP1 antibody, and bound Flag-TEAD4 was detected with an anti-Flag antibody. The binding of Flag-TEAD4 to endo-YAP1 was analyzed by immunoblotting, quantified by densitometry and normalized to the total abundance of endo-YAP1. Representative blots are shown. C , MAP4K4 overexpression and/or SASH1 silencing promoted the interaction between TEAD4 and YAP1 in MCF-7 cells. Flag-TEAD4 was immunoprecipitated with an anti-Flag antibody, and bound endo-YAP1 was detected with an anti-YAP1 antibody. The binding of endo-YAP1 to Flag-TEAD4 was analyzed by immunoblotting, quantified by densitometry and normalized to the total abundance of Flag-TEAD4. D , MAP4K4 overexpression and SASH1 silencing attenuated the association between YAP1 and TEAD1 in MCF-7 cells. Different combinations of FLAG- MAP4K4 , SASH1 -specific shRNA and GFP- TEAD1 were transfected into MCF-7 cells. Endo-YAP1 was immunoprecipitated with an anti-YAP1 antibody, and bound GFP-TEAD1 was detected with an anti-GFP antibody. The binding of GFP-TEAD1 to endo-YAP1 was analyzed through immunoblotting and normalized to the total abundance of endo-YAP1. The protein densitometry data in Figure 6 , A – D are expressed as the means ± SDs. The data were analyzed with one-way ANOVA for multiple comparisons in SPSS 16.0 software and plotted with GraphPad Prism 6.0. E and F , MAP4K4 overexpression and/or SASH1 silencing promoted the expression of YAP1 target genes, as shown by qRT‒PCR and immunoblotting. The Ct values of CTGF and CYR61 are expressed as the means ± SDs and were analyzed with one-way ANOVA for multiple comparisons. G and H , Significant increases in the expression of ERα , ERβ and PGR resulted from ectopic MAP4K4 expression and/or SASH1 silencing in MCF-7 cells, as indicated by qRT‒PCR. Ectopic MAP4K4 expression and/or SASH1 silencing resulted in increased expression of TP53 . The Ct values of ERα , ERβ , PGR and TP53 are expressed as the means ± SDs and were analyzed with one-way ANOVA for multiple comparisons. I , ectopic MAP4K4 and/or SASH1 silencing increased ERα expression in MCF-7 cells, as indicated by immunoblotting. J , the reduction in the p-YAP1 level in the MAP4K4-LATS-SASH1-YAP1 axis induced by PF-06260933 treatment was abolished by LATS2 silencing but not by LATS1 silencing. MCF-7 cells were transfected with either of two LATS1 siRNAs or LATS2 siRNAs. Twenty-four hours after transfection, the cells were treated with 20 μM PF-06260933 for 12 h, lysed and subjected to western blotting. K , downregulation of MAP4K4 and YAP1 and decreased levels of p-LATS2 resulted from PF-06260933 treatment of MCF-7 cells. MCF-7 cells were treated with 20 μM PF-06260933 for 12 h and lysed. The phosphorylation of endogenous MAP4K4 and SASH1 was assessed by the Phos-tag assay. # p < 0.05, ∗ p < 0.01, ∗∗ p < 0.001 versus control. L , downregulation of ERα, CYR61, CTGF, and YAP1 and an increased level of SASH1 resulted from PF-06260933 treatment of MCF-7 cells. The protein densitometry data in Figure 6 , I – K are expressed as the means ± SDs and were analyzed with one-way ANOVA for multiple comparisons. M , schematic diagram showing that YAP1 dephosphorylation and nuclear translocation of YAP1/TAZ are triggered by the combined effects of MAP4K4 upregulation and SASH1 silencing to activate the MAP4K4-LATS2-SASH1-YAP1/TAZ-TEAD4 cascade. N , schematic diagram showing that YAP1 downregulation and a decrease in the nuclear translocation of YAP1/TAZ resulted from MAP4K4 blockade caused by the use of MAP4K4-specific inhibitors or shRNAs to inhibit the activation of the MAP4K4-LATS2-SASH1-YAP1/TAZ-TEAD4 cascade. The schematic diagram was generated by Figdraw ( www.figdraw.com ).
Article Snippet: The cells were incubated with a mouse anti-SASH1 monoclonal antibody (MA5-24573, Thermo Fisher) and a rabbit anti-MAP4K4 polyclonal antibody (A301-502A, Bethyl Laboratories) overnight at 4 °C.
Techniques: Translocation Assay, Over Expression, Transfection, Protein Extraction, Expressing, shRNA, Immunoprecipitation, Binding Assay, Western Blot, Software, Phospho-proteomics, Control, De-Phosphorylation Assay, Activation Assay, Generated